Growth Metrics

Emergent BioSolutions (EBS) Work In Process (2016 - 2018)

Emergent BioSolutions has reported Work In Process over the past 8 years, most recently at $103.2 million for Q4 2018.

  • For Q4 2018, Work In Process rose 34.73% year-over-year to $103.2 million; the TTM value through Dec 2018 reached $103.2 million, up 34.73%, while the annual FY2018 figure was $103.2 million, 34.73% up from the prior year.
  • Work In Process for Q4 2018 was $103.2 million at Emergent BioSolutions, up from $64.8 million in the prior quarter.
  • Over five years, Work In Process peaked at $103.2 million in Q4 2018 and troughed at $14.8 million in Q3 2017.
  • A 5-year average of $44.1 million and a median of $34.0 million in 2014 define the central range for Work In Process.
  • Biggest five-year swings in Work In Process: crashed 39.59% in 2017 and later soared 338.72% in 2018.
  • Year by year, Work In Process stood at $33.5 million in 2014, then fell by 2.29% to $32.7 million in 2015, then plummeted by 39.4% to $19.8 million in 2016, then surged by 286.46% to $76.6 million in 2017, then soared by 34.73% to $103.2 million in 2018.
  • Business Quant data shows Work In Process for EBS at $103.2 million in Q4 2018, $64.8 million in Q3 2018, and $79.5 million in Q2 2018.